Printer Friendly
The Free Library
18,914,692 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Calypte Biomedical Corp Featured In July Issue Of Pennycents.


COLUMBIA, S.C. -- Excerpt from "Needle Phobia no more"

"Afraid of needles? You're not alone. "Needle phobia" is a recently defined medical condition that affects an estimated 10% of the population.

One of the biggest obstacles to widespread HIV testing is that many people find giving blood painful or unpleasant, so they do not seek testing. This reluctance, combined with cost and safety issues for blood-based testing, could make the control of HIV HIV (Human Immunodeficiency Virus), either of two closely related retroviruses that invade T-helper lymphocytes and are responsible for AIDS. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is responsible for the vast majority of AIDS in the United States.  difficult, especially in developing countries.

According to the United States Center for Disease Control (CDC See Control Data, century date change and Back Orifice.

CDC - Control Data Corporation
), approximately 275,000 Americans currently infected with HIV-1 are unaware of their status because they have not undergone testing. And outside the U.S., this number is much higher. With so many people unaware that they are infected, controlling the spread of AIDS is extremely difficult.

Until recently, the only reliable means of testing for HIV infection was by blood, which might have kept a large part of the population from seeking proper medical attention. But a fear of getting poked no longer has to stand in the way of being tested.

Calypte Biomedical Corporation (OTCBB OTCBB

See OTC Bulletin Board (OTCBB).
: CYPT) is an Almeda, California healthcare company"

To read the rest of this story visit www.pennycents.com.

Other featured articles include

COVAD COVAD Combined Voice and Data
COVAD Copper Value Added (company) 
 COMMS GP (OTCBB: COVD COVD College of Optometrists in Vision Development
COVD Covad Communications Group (stock symbol) 
) a provider of high-speed Internet connectivity and related communications services. Its services include a range of high-speed, high-capacity or broadband Internet access Broadband Internet access, often shortened to just "broadband", is high speed Internet access—typically contrasted with dial-up access over modem.

Dial-up modems are generally only capable of a maximum bitrate of 56 kbit/s (kilobits per second) and require the full use of a
 connectivity and related services

ENDEVCO INC (OTCBB: ENDE ENDE Electromagnetic Non-Destructive Evaluation (workshop) ) an energy company establishing an identity that is consistent with its business development activities.

GLOBETEL (OTCBB: GTEL) a company engaged in the business of providing telecommunication services primarily involving Internet telephony using voice-over Internet protocol (VoIP) equipment.

IPVOICE COMMS (OTCBB: IPVO) a development stage company focused on developing and producing its proprietary software solutions for use in Internet Telephony (IP Telephony).

About Pennycents magazine

Pennycents is a monthly tearout featuring OTCBB companies. The independent magazine writes information based articles on companies that are publicly traded on the over-the-counter bulletin boards. You can have Pennycents mailed to your door or learn more about their products by visiting their website, www.pennycents.com.
COPYRIGHT 2004 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jul 1, 2004
Words:352
Previous Article:Mayfair Lakes Golf and Country Club Doubles Cart Revenue and Wows the Canadian Tour with the Inforemer Solution.
Next Article:Zacks Sell List Highlights: Krispy Kreme, Pier 1 Imports, Knight Trading Group, and Washington Mutual.



Related Articles
Calypte Biomedical Corp. announces initial public offering of common stock.
Calypte reports second quarter results.
Calypte Biomedical and Cambridge Biotech complete urine Western blot submission.
Calypte reports first quarter results.
Calypte Reports Second Quarter Results.
U.S. FDA Issues "Review Complete" Notice for Urine HIV-1 Confirmation Test.
Two HIV tests prove better than one. (using both urine and blood tests for HIV was found to be more reliable according to a study at Calypte...
Calypte to Host Conference Call to Discuss Second Quarter 2001 Earnings Results.
Calypte Announces Second Quarter Conference Call and Webcast.
J.M. Dutton & Associates Announces Investment Opinion: Calypte Biomedical Neutral Rating in Initiating Coverage by Dutton & Associates.

Terms of use | Copyright © 2010 Farlex, Inc. | Feedback | For webmasters | Submit articles